Abstract
Decision letter for "E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora and HSP90 in preclinical models"
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have